Pim B van der Meer

13PUBLICATIONS
23CO-AUTHORS
Toxicology (incl. clinical toxicology)Predictive and prognostic markersPacific Peoples and disabilityCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 14, 2026
Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.

|Apr 29, 2025
Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients: A Prospective Observational Study.

Pim B van der Meer, Melissa Kerkhof, Linda Dirven

|Jul 20, 2024
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.

Anton Gomez-Escolar, Daniel Folch-Sanchez, Joanna Stefaniuk

|Jul 17, 2023
Depression and anxiety in glioma patients.

Pim B van der Meer, Linda Dirven, Caroline Hertler

|Feb 08, 2023
Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study.

Pim B van der Meer, Linda Dirven, Marta Fiocco

|Nov 16, 2022
First-line levetiracetam versus enzyme-inducing antiseizure medication in glioma patients with epilepsy.

Pim B van der Meer, Marta Maschio, Linda Dirven

Pageof 3

Frequent Collaborators

3 joint publications

Linda Dirven

3 joint publications

Mathilde Kouwenhoven

2 joint publications

Florien W Boele

2 joint publications

Johan Koekkoek